Role of PET/CT in post-therapeutic assessment of bronchogenic carcinoma

Role of PET/CT in post-therapeutic assessment of bronchogenic carcinoma

Abstract Background Lung cancer is the most common among all kinds of cancers. It still constitutes the leading cause of cancer-related deaths worldwide, even with major advancements in prevention and treatments available. More than 85% of the cases are of non-small cell lung cancer (NSCLC), while l...

Full description

Bibliographic Details
Main Authors:	Amira Ayman Shaheen, Ahmed Mostafa Mohammed, Ahmed Elshimy, Mennatallah Hatem Shalaby
Format:	Article
Language:	English
Published:	SpringerOpen 2021-05-01
Series:	The Egyptian Journal of Radiology and Nuclear Medicine
Subjects:	Bronchogenic carcinoma Treatment response PET/CT SUVmax RECIST
Online Access:	https://doi.org/10.1186/s43055-021-00503-3

Similar Items

Bronchogenic carcinoma: the added value of FDG PET/CT advanced volumetric and metabolic parameters in initial evaluation and their impact on prognosis and clinical outcome
by: Momena Essam Ibrahim Elsadawy, et al.
Published: (2024-02-01)

Prognostic value of pre-treatment FDG PET/CT SUVmax for metastatic lesions in de novo metastatic nasopharyngeal carcinoma following chemotherapy and locoregional radiotherapy
by: Wenbin Yan, et al.
Published: (2023-02-01)

Beyond lymph nodes: 18F-FDG PET/CT in detection of unusual sites of extranodal lymphoma
by: Amal Ibrahim Ahmed Othman, et al.
Published: (2019-09-01)

Prediction of 2-[<sup>18</sup>F]FDG PET-CT SUVmax for Adrenal Mass Characterization: A CT Radiomics Feasibility Study
by: Arnaldo Stanzione, et al.
Published: (2023-06-01)

Analysis of the Role of PET/CT SUVmax in Prognosis and Its Correlation with  Clinicopathological Characteristics in Resectable Lung Squamous Cell Carcinoma
by: Hongliang REN, et al.
Published: (2016-04-01)

FDG-PET/CT tumor to liver SUV ratio (TLR), tumor SUVmax, and tumor size: can this help in differentiating squamous cell carcinoma from adenocarcinoma of the lung?
by: Amr Muhammad Abdo Salem, et al.
Published: (2022-05-01)

Construction and validation of an 18F-FDG-PET/CT-based prognostic model to predict progression-free survival in newly diagnosed multiple myeloma patients
by: Xiaoqing Dong, et al.
Published: (2024-12-01)

DARS2 overexpression is associated with PET/CT metabolic parameters and affects glycolytic activity in lung adenocarcinoma
by: Xu-Sheng Liu, et al.
Published: (2023-08-01)

Hounsfield unit value has null effect on thyroid nodules at 18F-FDG PET/CT scans
by: Filiz Eksi Haydardedeoglu, et al.

Use of F-18 FDG PET/CT Through Delayed Diuretic Imaging for Preoperative Evaluation of Upper Urinary Tract-Occupying Lesions
by: Jun Wang, et al.
Published: (2021-08-01)

Response criteria in solid tumors (PERCIST/RECIST) and SUVmax in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapy
by: Cory Pierson, et al.
Published: (2018-02-01)

Glucose Metabolism Quantified by SUVmax on Baseline FDG-PET/CT Predicts Survival in Newly Diagnosed Multiple Myeloma Patients: Combined Harmonized Analysis of Two Prospective Phase III Trials
by: Anne-Victoire Michaud-Robert, et al.
Published: (2020-09-01)

FDG-PET/CT Versus Contrast-Enhanced CT for Response Evaluation in Metastatic Breast Cancer: A Systematic Review
by: Fredrik Helland, et al.
Published: (2019-08-01)

FDG‐PET/CT‐guided rebiopsy may find clinically unsuspicious transformation of follicular lymphoma
by: Aino Rajamäki, et al.
Published: (2023-01-01)

Significance of metabolic parameters and biochemical indexes of 18F-FDG PET/CT in the mid-term evaluation and prognosis of diffuse large B-cell lymphoma
by: Zhang Fan, Zhang Guoxu, Liu Xiuting, Wang Jigang, Liu Yanqin, Tong Danjiang, Liu Jinghua, Zhou Fan
Published: (2022-03-01)

Metastatic Bronchogenic Carcinoma to the Mandible
by: Butt FMA, et al.
Published: (2016-01-01)

Cervical bronchogenic cyst
by: Bahar Ashjaei, et al.
Published: (2020-12-01)

Avaliação do SUVmax na captação do [68Ga]Ga-DOTA-TATE PET/CT em doentes com tumores neuroendócrinos: revisão de literatura
by: Carolina Maricato, et al.
Published: (2022-11-01)

Evaluating the value of 18F-PSMA-1007 PET/CT in the detection and identification of prostate cancer using histopathology as the standard
by: Liang Luo, et al.
Published: (2023-11-01)

Clinical Impact of Dual Time Point <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging in Pancreatic Cancer
by: Takahiro Einama, et al.
Published: (2022-07-01)

The Value of Semiquantitative Parameters Derived from <sup>18</sup>F-FDG PET/CT for Predicting Response to Neoadjuvant Chemotherapy in a Cohort of Patients with Different Molecular Subtypes of Breast Cancer
by: Luca Urso, et al.
Published: (2022-11-01)

Diagnosis value of 18F-Fluoro-d-glucose positron emission tomography-computed tomography in pulmonary hamartoma: a retrospective study and systematic review
by: Sheng Ye, et al.
Published: (2023-02-01)

Clinical utility of 18F-FDG PET/CT imaging in patients with pulmonary artery sarcoma
by: Jingyun Ren, et al.
Published: (2022-04-01)

Diagnostic performance of PET/CT in primary malignant bone tumors
by: Ahmed Eid Fahim Abdella, et al.
Published: (2021-09-01)

Diagnostic Accuracy of Contrast Enhanced Computed Tomography in Detecting Bronchogenic Carcinoma-Experience At Liaquat National Hospital
by: Nazish Khaliq, et al.
Published: (2017-04-01)

Diagnostic Accuracy of Contrast Enhanced Computed Tomography in Detecting Bronchogenic Carcinoma-Experience At Liaquat National Hospital
by: Nazish Khaliq, et al.
Published: (2017-04-01)

Diagnostic Accuracy of Contrast Enhanced Computed Tomography in Detecting Bronchogenic Carcinoma-Experience At Liaquat National Hospital
by: Nazish Khaliq, et al.
Published: (2017-04-01)

The effect of hepatic steatosis on 18F-FDG uptake in PET-CT examinations of cancer Egyptian patients
by: Magdi A. Ali, et al.
Published: (2023-10-01)

Is CT or FDG-PET more useful for evaluation of the treatment response in metastatic HER2-positive breast cancer? a case report and literature review
by: Hirotaka Suto, et al.
Published: (2023-04-01)

Value of 18F-FDG PET/CT Parameters and Deauville 5-point Scoring in Efficacy Evaluation and Prognosis Prediction of Diffuse Large B Cell Lymphoma Patients
by: YANG Ming, et al.
Published: (2020-08-01)

Application of 18F-FDG PET-CT Images Based Radiomics in Identifying Vertebral Multiple Myeloma and Bone Metastases
by: Zhicheng Jin, et al.
Published: (2022-04-01)

A case of primary small cell neuroendocrine carcinoma of the uterus
by: Taku Miyanaga, MD, et al.
Published: (2022-11-01)

Clinical and radiological manifestations of paraneoplastic syndrome of bronchogenic carcinoma
by: Goldner Branislav, et al.
Published: (2005-01-01)

Multiple myeloma: characterization of patients through the analysis of semiquantitative parameters with 18F-FDG PET
by: Maria Silvia De Feo, et al.
Published: (2023-06-01)

The Bronchogenic cyst: a diagnostic challenge as cervical swelling
by: Bipin Kishore Prasad, et al.
Published: (2023-03-01)

The Bronchogenic cyst: a diagnostic challenge as cervical swelling
by: Bipin Kishore Prasad, et al.
Published: (2023-03-01)

A bronchogenic cyst presenting as a presternal abscess
by: Maria Shilova, et al.
Published: (2020-12-01)

Prognostic factors associated with 18FDG-PET/CT in esophageal squamous cell carcinoma after trimodality treatment
by: Wei-Hsiang Feng, et al.
Published: (2022-07-01)

Prognostic value of maximum standard uptake value, metabolic tumour volume, and total lesion glycolysis of 18F-FDG PET/CT in patients with malignant pleural mesothelioma: a systematic review and meta-analysis
by: Weibo Wen, et al.
Published: (2022-02-01)

The ability of whole-body SUVmax in F-18 FDG PET/CT to predict suboptimal cytoreduction during primary debulking surgery for advanced ovarian cancer
by: Gun Oh. Chong, et al.
Published: (2019-02-01)